This website uses cookies to enhance the user experience.
C

CYTOVATION ASA983 644 600

Research
Public limited company
Solheimsgaten 11 5058 BERGEN, Norge

CYTOVATION ASA

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

Chairman of the board
Years since formation
23 years
since Sep 6, 2001
Type
Public limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
242,417
1 share class
Total number of shareholders
20
14 companies, 6 persons

Financials

Annual total result 2023
-81,511,885
NOK
Total equity 2023
-30,436,620
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
9.92 %
indirectly

Board

NameRoleShares
Chairman
1.84 %
indirectly
Board Member-
Board Member-
Board Member-
Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
V
VIEW LEDGER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO
9.92 %
indirectly
-
9.9 %
directly
-
9.86 %
directly
-
2.88 %
indirectly
-
2.48 %
indirectly
-
2.2 %
directly
-
2.19 %
indirectly
-
2 %
indirectly
-
1.89 %
indirectly
Chairman
1.84 %
indirectly
Last update: Mar 9, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
C
CYTO INVEST AS
NO0012518952
83,746
34.55 %
I
INNOVEST AS
NO0012518952
47,700
19.68 %
L
LP-INVEST AS
NO0012518952
24,052
9.92 %
NO0012518952
23,994
9.9 %
NO0012518952
23,900
9.86 %
C
CANICA AS
NO0012518952
10,680
4.41 %
C
CYTOVATION ASA
NO0012518952
6,995
2.89 %
M
MNG HOLDING BERGEN AS
NO0012518952
5,612
2.32 %
NO0012518952
5,339
2.2 %
P
PACTUM VEKST AS
NO0012518952
4,272
1.76 %
NO0012518952
1,500
0.62 %
H
HEALTH CARE INVEST AS
NO0012518952
1,323
0.55 %
G
GEIR GULLIKSEN INVEST AS
NO0012518952
944
0.39 %
Z
ZINOBER INVEST AS
NO0012518952
814
0.34 %
NO0012518952
500
0.21 %
N
NIAN AS
NO0012518952
464
0.19 %
A
ASTON AS
NO0012518952
281
0.12 %
P
PLAN ELBRUS AS
NO0012518952
171
0.07 %
NO0012518952
107
0.04 %
S
SANDVANN AS
NO0012518952
22
< 0.01 %

Shares owned by the CYTOVATION ASA

NameShare classNumber of sharesShare
C
CYTOVATION ASA
NO0012518952
6,995
2.89 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-81,511,885
-122,909,417
-34,365,250
Total assets
78,156,381
83,917,564
107,451,738
Total liabilities
108,593,001
32,842,299
20,341,570
Total equity
-30,436,620
51,075,265
87,110,169

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
77,245,362
122,064,133
33,705,659
Operating result
-77,245,362
-122,064,133
-33,705,659
Financial income/costs
-4,266,523
-845,284
-659,591
Profit before tax
-81,511,885
-122,909,417
-34,365,250
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-81,511,885
-122,909,417
-34,365,250

Balance overview

Year202320222021
Total fixed assets
274,258
94,163
31,663
Total current assets
77,882,122
83,823,401
107,420,075
Total assets
78,156,381
83,917,564
107,451,738
Short term debt
17,467,062
21,936,315
9,435,586
Long term debt
91,125,939
10,905,984
10,905,984
Total liabilities
108,593,001
32,842,299
20,341,570
Contributed capital
1,212,085
51,075,265
99,107,132
Retained earnings
-31,648,705
0
-11,996,963
Total equity
-30,436,620
51,075,265
87,110,169
Total equity and liabilities
78,156,381
83,917,564
107,451,738

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering